Literature DB >> 21984541

Increased basal coronary blood flow as a cause of reduced coronary flow reserve in diabetic patients.

Andrea Picchi1, Ugo Limbruno, Marta Focardi, Bernardo Cortese, Andrea Micheli, Letizia Boschi, Silva Severi, Raffaele De Caterina.   

Abstract

A reduced coronary flow reserve (CFR) has been demonstrated in diabetes, but the underlying mechanisms are unknown. We assessed thermodilution-derived CFR after 5-min intravenous adenosine infusion through a pressure-temperature sensor-tipped wire in 30 coronary arteries without significant lumen reduction in 30 patients: 13 with and 17 without a history of diabetes. We determined CFR as the ratio of basal and hyperemic mean transit times (T(mn)); fractional flow reserve (FFR) as the ratio of distal and proximal pressures at maximal hyperemia to exclude local macrovascular disease; and an index of microvascular resistance (IMR) as the distal coronary pressure at maximal hyperemia divided by the inverse of the hyperemic T(mn). We also assessed insulin resistance by the homeostasis model assessment (HOMA) index. FFR was normal in all investigated arteries. CFR was significantly lower in diabetic vs. nondiabetic patients [median (interquartile range): 2.2 (1.4-3.2) vs. 4.1 (2.7-4.4); P = 0.02]. Basal T(mn) was lower in diabetic vs. nondiabetic subjects [median (interquartile range): 0.53 (0.25-0.71) vs. 0.64 (0.50-1.17); P = 0.04], while hyperemic T(mn) and IMR were similar. We found significant correlations at linear regression analysis between logCFR and the HOMA index (r(2) = 0.35; P = 0.0005) and between basal T(mn) and the HOMA index (r(2) = 0.44; P < 0.0001). In conclusion, compared with nondiabetic subjects, CFR is lower in patients with diabetes and epicardial coronary arteries free of severe stenosis, because of increased basal coronary flow, while hyperemic coronary flow is similar. Basal coronary flow relates to insulin resistance, suggesting a key role of cellular metabolism in the regulation of coronary blood flow.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21984541     DOI: 10.1152/ajpheart.00615.2011

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  17 in total

1.  Insulin resistance is a major determinant of myocardial blood flow impairment in anginal patients.

Authors:  Riccardo Liga; Daniele Rovai; Tiziana Sampietro; Cecilia Vecoli; Giancarlo Todiere; Chiara Caselli; Giuseppe Rossi; Antonio L'abbate; Danilo Neglia
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-09-11       Impact factor: 9.236

2.  Impaired coronary and retinal vasomotor function to hyperoxia in Individuals with Type 2 diabetes.

Authors:  Mary E Lott; Julia E Slocomb; Zhaohui Gao; Robert A Gabbay; David Quillen; Thomas W Gardner; Kerstin Bettermann
Journal:  Microvasc Res       Date:  2015-05-20       Impact factor: 3.514

Review 3.  Regulation of Coronary Blood Flow.

Authors:  Adam G Goodwill; Gregory M Dick; Alexander M Kiel; Johnathan D Tune
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

4.  Myocardial perfusion in patients with non-ischaemic systolic heart failure and type 2 diabetes: a cross-sectional study using Rubidium-82 PET/CT.

Authors:  Christina Byrne; Philip Hasbak; Andreas Kjaer; Jens Jakob Thune; Lars Køber
Journal:  Int J Cardiovasc Imaging       Date:  2017-12-28       Impact factor: 2.357

5.  Influence of diabetes mellitus on the diagnostic performance of machine learning-based coronary CT angiography-derived fractional flow reserve: a multicenter study.

Authors:  Yi Xue; Min Wen Zheng; Yang Hou; Fan Zhou; Jian Hua Li; Yi Ning Wang; Chun Yu Liu; Chang Sheng Zhou; Jia Yin Zhang; Meng Meng Yu; Bo Zhang; Dai Min Zhang; Yan Yi; Lei Xu; Xiu Hua Hu; Guang Ming Lu; Chun Xiang Tang; Long Jiang Zhang
Journal:  Eur Radiol       Date:  2022-01-12       Impact factor: 5.315

6.  Acute hyperglycaemia enhances both vascular endothelial function and cardiac and skeletal muscle microvascular function in healthy humans.

Authors:  William B Horton; Linda A Jahn; Lee M Hartline; Kevin W Aylor; James T Patrie; Eugene J Barrett
Journal:  J Physiol       Date:  2021-02-02       Impact factor: 5.182

7.  Coronary Flow Reserve and Glycemic Variability in Patients with Coronary Artery Disease.

Authors:  Takeshi Nishi; Yuichi Saito; Hideki Kitahara; Tomoko Nishi; Yoshihide Fujimoto; Yoshio Kobayashi
Journal:  Intern Med       Date:  2020-11-02       Impact factor: 1.271

Review 8.  Vasomotor Dysfunction in Patients with Ischemia and Non-Obstructive Coronary Artery Disease: Current Diagnostic and Therapeutic Strategies.

Authors:  Amr Abouelnour; Tommaso Gori
Journal:  Biomedicines       Date:  2021-11-26

9.  Angina relates to coronary flow in women with ischemia and no obstructive coronary artery disease.

Authors:  Nissi Suppogu; Janet Wei; Odayme Quesada; Chrisandra Shufelt; Galen Cook-Wiens; Bruce Samuels; John W Petersen; R David Anderson; Eileen M Handberg; Carl J Pepine; C Noel Bairey Merz
Journal:  Int J Cardiol       Date:  2021-03-01       Impact factor: 4.039

10.  New concept of myocardial longitudinal strain reserve assessed by a dipyridamole infusion using 2D-strain echocardiography: the impact of diabetes and age, and the prognostic value.

Authors:  Thomas Cognet; Paul-Louis Vervueren; Laurent Dercle; Delphine Bastié; Rainui Richaud; Matthieu Berry; Pauline Marchal; Matthieu Gautier; Audrey Fouilloux; Michel Galinier; Didier Carrié; Pierre Massabuau; Isabelle Berry; Olivier Lairez
Journal:  Cardiovasc Diabetol       Date:  2013-06-07       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.